CEO Mike – Talk Bio

Actionable Insights Powered by AI

Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama

Novo Nordisk; Metsera; acquisition; Pfizer; buyout; obesity drugs; analysts; lawsuit; antitrust; CEO Mike Doustdar